Document Detail


Long-term follow-up of 111 patients with angiotensin-converting enzyme inhibitor-related angioedema.
MedLine Citation:
PMID:  21970934     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: To investigate, for the first time, the frequency of recurrences of angiotensin-converting enzyme inhibitor (ACE-I)-related angioedema after the discontinuation of ACE-I.
METHODS: This retrospective study was conducted in an outpatient tertiary-level centre for a total period of 173 months (about 14 years). Consecutive patients with recurrent angioedema symptoms, initiated during treatment with an ACE-I, who had been followed for at least 12 months after discontinuation of the drug were eligible. The primary study variable was the incidence of recurrences of angioedema after ACE-I discontinuation. Angioedema location, type of ACE-I and indication for this treatment and the drugs prescribed after the discontinuation of ACE-I were also evaluated.
RESULTS: In total, 111 patients were followed; 54 of them (49%) were on enalapril. After discontinuation from ACE-I, 51 patients (46%) had further recurrences of angioedema; in 18 relapsers (16% of the total), the frequency of angioedema recurrences remained unchanged when compared with that reported during ACE-I treatment. The large majority of relapsers (88%) had the first recurrence of angioedema within the first month since ACE-I discontinuation. The switch to a different antihypertensive therapy did not seem associated with a reduction in the frequency of angioedema attacks.
CONCLUSION: Even with all the limitations on any observational analysis, this long-term study suggests for the first time that patients with angioedema started while on ACE-I treatment seem to have a condition predisposing to angioedema that is elicited by the treatment with these drugs. Further studies in this field appear advocated due to the potential severity of angioedema attacks.
Authors:
Laura Beltrami; Andrea Zanichelli; Lorenza Zingale; Romualdo Vacchini; Stefano Carugo; Marco Cicardi
Related Documents :
22167244 - Implementation of intravenous to oral antibiotic switch therapy guidelines in the gener...
21830124 - Basic and clinical research on the therapeutic effect of intervention in primary liver ...
21917434 - Impact of metabolic syndrome on clinical outcomes after new generation drug-eluting ste...
9362184 - Helicobacter pylori recurrence after successful eradication: 5-year follow-up in the un...
21153524 - Navigated retrograde drilling in ocd of the talus.
7776454 - Further experience with the modified ileal ureter.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of hypertension     Volume:  29     ISSN:  1473-5598     ISO Abbreviation:  J. Hypertens.     Publication Date:  2011 Nov 
Date Detail:
Created Date:  2011-10-12     Completed Date:  2012-03-22     Revised Date:  2014-03-19    
Medline Journal Info:
Nlm Unique ID:  8306882     Medline TA:  J Hypertens     Country:  England    
Other Details:
Languages:  eng     Pagination:  2273-7     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Aged, 80 and over
Angioedema / drug therapy*,  epidemiology,  pathology
Angiotensin-Converting Enzyme Inhibitors / pharmacology*
Cardiology / methods
Female
Follow-Up Studies
Humans
Male
Middle Aged
Recurrence
Retrospective Studies
Treatment Outcome
Grant Support
ID/Acronym/Agency:
GGP08223//Telethon
Chemical
Reg. No./Substance:
0/Angiotensin-Converting Enzyme Inhibitors

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Total knee arthroplasty in elderly osteoporotic patients.
Next Document:  Pathogenesis and management of hypertension after kidney transplantation.